Handan Xiang

691 total citations
10 papers, 424 citations indexed

About

Handan Xiang is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Handan Xiang has authored 10 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Immunology and 4 papers in Oncology. Recurrent topics in Handan Xiang's work include Immune cells in cancer (3 papers), Epigenetics and DNA Methylation (3 papers) and Telomeres, Telomerase, and Senescence (3 papers). Handan Xiang is often cited by papers focused on Immune cells in cancer (3 papers), Epigenetics and DNA Methylation (3 papers) and Telomeres, Telomerase, and Senescence (3 papers). Handan Xiang collaborates with scholars based in United States, China and Singapore. Handan Xiang's co-authors include Yanlin Jia, An Chi, Yi Ding, Lifeng Yuan, Dongyu Sun, Josephine Hai, Huijun Wang, Carlo P. Ramil, Lily Y. Moy and Philip E. Brandish and has published in prestigious journals such as Nature Communications, EMBO Reports and Cell Research.

In The Last Decade

Handan Xiang

10 papers receiving 420 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Handan Xiang United States 8 236 149 146 105 62 10 424
Yael Morgenstern Israel 4 228 1.0× 87 0.6× 118 0.8× 60 0.6× 76 1.2× 9 364
Paola Ortíz-Montero Colombia 7 181 0.8× 150 1.0× 153 1.0× 56 0.5× 165 2.7× 9 423
Gabriela Vazquez Rodriguez Sweden 9 128 0.5× 144 1.0× 184 1.3× 92 0.9× 25 0.4× 12 374
Jingwei Sim Singapore 5 217 0.9× 179 1.2× 86 0.6× 178 1.7× 45 0.7× 11 436
Kevin O’Hayer United States 10 315 1.3× 113 0.8× 263 1.8× 88 0.8× 18 0.3× 18 568
Liwei Xiao China 5 244 1.0× 128 0.9× 88 0.6× 198 1.9× 29 0.5× 7 434
Douglas B. Fox United States 7 358 1.5× 57 0.4× 117 0.8× 191 1.8× 67 1.1× 8 505
Byung–Kyu Ryu South Korea 10 374 1.6× 63 0.4× 135 0.9× 120 1.1× 29 0.5× 11 562
Sara Morlacchi Italy 7 152 0.6× 314 2.1× 149 1.0× 45 0.4× 34 0.5× 8 474
Sundary Sormendi Germany 6 155 0.7× 93 0.6× 66 0.5× 134 1.3× 22 0.4× 8 319

Countries citing papers authored by Handan Xiang

Since Specialization
Citations

This map shows the geographic impact of Handan Xiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Handan Xiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Handan Xiang more than expected).

Fields of papers citing papers by Handan Xiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Handan Xiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Handan Xiang. The network helps show where Handan Xiang may publish in the future.

Co-authorship network of co-authors of Handan Xiang

This figure shows the co-authorship network connecting the top 25 collaborators of Handan Xiang. A scholar is included among the top collaborators of Handan Xiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Handan Xiang. Handan Xiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Tan, Lianmei, Tao Yin, Handan Xiang, et al.. (2024). Aberrant cytoplasmic expression of UHRF1 restrains the MHC-I-mediated anti-tumor immune response. Nature Communications. 15(1). 8569–8569. 10 indexed citations
2.
Ramil, Carlo P., Handan Xiang, Peng Zhang, et al.. (2024). Extracellular vesicles released by cancer-associated fibroblast-induced myeloid-derived suppressor cells inhibit T-cell function. OncoImmunology. 13(1). 2300882–2300882. 10 indexed citations
3.
Yuan, Hongyan, Lü Jin, Handan Xiang, et al.. (2022). Resistance of MMTV-NeuT/ATTAC mice to anti-PD-1 immune checkpoint therapy is associated with macrophage infiltration and Wnt pathway expression. Oncotarget. 13(1). 1350–1358. 2 indexed citations
4.
Xiang, Handan, Carlo P. Ramil, Josephine Hai, et al.. (2020). Cancer-Associated Fibroblasts Promote Immunosuppression by Inducing ROS-Generating Monocytic MDSCs in Lung Squamous Cell Carcinoma. Cancer Immunology Research. 8(4). 436–450. 190 indexed citations
5.
Xiang, Handan, Carlo P. Ramil, Josephine Hai, et al.. (2020). Abstract A98: Cancer-associated fibroblasts promote immunosuppression by inducing NOX2-expressing monocytic MDSCs in lung squamous cell carcinoma. Cancer Immunology Research. 8(3_Supplement). A98–A98. 1 indexed citations
6.
Ding, Yi, Chang Gong, De Huang, et al.. (2018). Synthetic lethality between HER2 and transaldolase in intrinsically resistant HER2-positive breast cancers. Nature Communications. 9(1). 4274–4274. 27 indexed citations
7.
Yuan, Lifeng, Linhui Zhai, Lili Qian, et al.. (2018). Switching off IMMP2L signaling drives senescence via simultaneous metabolic alteration and blockage of cell death. Cell Research. 28(6). 625–643. 41 indexed citations
8.
Chong, Mengyang, Tao Yin, Rui Chen, et al.. (2018). CD 36 initiates the secretory phenotype during the establishment of cellular senescence. EMBO Reports. 19(6). 54 indexed citations
9.
Xiang, Handan, Lifeng Yuan, Xia Gao, et al.. (2017). UHRF1 is required for basal stem cell proliferation in response to airway injury. Cell Discovery. 3(1). 17019–17019. 28 indexed citations
10.
Kishton, Rigel J., Andrew N. Macintyre, Valerie A. Gerriets, et al.. (2014). Glucose transporter 1-mediated glucose uptake is limiting for B-cell acute lymphoblastic leukemia anabolic metabolism and resistance to apoptosis. Cell Death and Disease. 5(10). e1470–e1470. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026